Avalyn Pharma Inc. ($AVLN)
Filing Information
| Accession Number | 0001388325-26-000021 |
|---|---|
| Form Type | 4 |
| Filing Date | May 5, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
67,914,626
Total Value
$9,999,990.00
P&L
+52.4% (+$5,238,883.65)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Voting Common Stock | โ | May 1, 2026 | Conversion | 3,327,734 | โ | โ | 3,327,734 | Direct | โ | View Details | |
10% Owner | Voting Common Stock | โ | May 1, 2026 | Purchase | 555,555 | $18.00 | $9,999,990.00 | 3,883,289 | Direct | โ | View Details | |
10% Owner | Series A Preferred Stock | Derivative | May 1, 2026 | Conversion | 18,000,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
10% Owner | Series B Preferred Stock | Derivative | May 1, 2026 | Conversion | 1,986,369 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
10% Owner | Series C-1 Preferred Stock | Derivative | May 1, 2026 | Conversion | 25,899,284 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
10% Owner | Series C-2 Preferred Stock | Derivative | May 1, 2026 | Conversion | 5,587,603 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
10% Owner | Series D Preferred Stock | Derivative | May 1, 2026 | Conversion | 12,558,081 | $0.00 | $0.00 | 0 | Direct | โ | View Details |